RadNet, Inc. RDNT
General analysis — not personal advice.
Raised full-year guidance and strong same-center/volume growth strengthen the bull case, but profitability remains weak (net loss and Digital Health segment loss) and integration/investment costs (including Gleamer) may continue to pressure earnings.
This picture changes. Follow RadNet, Inc. free — email when the signal or risk changes + a Sunday weekly brief.
Follow RadNet, Inc. freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Price & valuation
Market sentiment
Why NEUTRAL?
- Hold/wait and reassess after the market digests the raised guidance; consider adding only with clearer evidence of net income/FCF conversion or a steadier margin trend.
Recent News
- On August 9, 2026, RadNet reported second-quarter 2026 financial results, posting record quarterly revenue of $622.7 million, up 25% year-over-year. The performance was driven by higher procedural volumes in advanced imaging and rapid growth in its Digital Health division. Following the results, the company raised its full-year 2026 financial guidance for imaging center revenue and adjusted EBITDA.
Catalysts
Raised 2026 guidance (Imaging Centers)
Dilution Risk
Assessment: Medium
What Firelda Watch includes for RadNet, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Own RadNet, Inc.? Create a free account and follow up to 3 companies — change history, weekly brief, and email when the picture changes. Upgrade to Watch for more slots and same-day alerts.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more